CYTK
#970
Cytokinetics, Incorporated - Common Stock
62.9 1 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.45%
Variación mensual
-14.42%
Variación en los últimos 6 meses
-3.23%
Cambio anual
+8.28%
Cierres anteriores
62.0 1
Open
61.8 7
Mínimo
61.5 9
Máximo
63.0 3
Financials
- Market Capitalization 8.75 B
- Employee 673
- Founded 1997
- CEO Robert I. Blum | Robert I. Blum
- Website www.cytokinetics.com
- Headquarter California, United States
- FIGI BBG000F0R4N9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.72
Relación precio/flujo de caja
0.09
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 961 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 62.75 USD | +3.31% | -3.10% | -24.13% | +60.49% | 8.86 B USD | ||
| 966 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 168.35 USD | -1.02% | -6.08% | -24.14% | +29.30% | 8.82 B USD | ||
| 983 |  TGTX TG Therapeutics, Inc. - Common Stock | 55.37 USD | +3.81% | +1.95% | +2.59% | +64.45% | 8.48 B USD | ||
| 1043 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 85.69 USD | +7.25% | -7.88% | -5.42% | +258.39% | 7.56 B USD |